With ACORA we are developing an interventional treatment approach for patients suffering from symptomatic mitral valve regurgitation.
The ACORA concept is based on a hybrid approach - the implant is intended to seal the coaptation gap of the insufficient mitral valve and restore the function through an integrated biological valve.
The valve portion of the implant is positioned in the native mitral valve annulus. The anchoring of ACORA takes place via a catheter-based transapical access in the apex.
With the help of the natural valve leaflets, the implant is intended to prevent the backflow into the atrium during systole. Thereby the pressure separation to the ventricle will be restored. In diastole, the integrated valve of the implant shall be opened by the blood flow and enable the inflow into the left ventricle with low resistance.
Transcatheter Repair System for Mitral Regurgitation
Device under development - commercially not available.
